NM_001854.4:c.1351-76G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.1351-76G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.692 in 1,160,478 control chromosomes in the GnomAD database, including 285,780 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 30128 hom., cov: 31)
Exomes 𝑓: 0.71 ( 255652 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.203

Publications

11 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-103017958-C-T is Benign according to our data. Variant chr1-103017958-C-T is described in ClinVar as Benign. ClinVar VariationId is 674750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.892 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.1351-76G>A intron_variant Intron 10 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.1351-76G>A intron_variant Intron 10 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.599
AC:
90844
AN:
151750
Hom.:
30126
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.289
Gnomad AMI
AF:
0.884
Gnomad AMR
AF:
0.687
Gnomad ASJ
AF:
0.681
Gnomad EAS
AF:
0.913
Gnomad SAS
AF:
0.831
Gnomad FIN
AF:
0.700
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.701
Gnomad OTH
AF:
0.625
GnomAD4 exome
AF:
0.706
AC:
712579
AN:
1008610
Hom.:
255652
AF XY:
0.712
AC XY:
371691
AN XY:
522036
show subpopulations
African (AFR)
AF:
0.278
AC:
6808
AN:
24486
American (AMR)
AF:
0.693
AC:
30306
AN:
43738
Ashkenazi Jewish (ASJ)
AF:
0.663
AC:
15307
AN:
23090
East Asian (EAS)
AF:
0.926
AC:
34810
AN:
37612
South Asian (SAS)
AF:
0.826
AC:
63604
AN:
77018
European-Finnish (FIN)
AF:
0.699
AC:
36958
AN:
52880
Middle Eastern (MID)
AF:
0.653
AC:
2827
AN:
4330
European-Non Finnish (NFE)
AF:
0.701
AC:
490812
AN:
700268
Other (OTH)
AF:
0.689
AC:
31147
AN:
45188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
10237
20474
30710
40947
51184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9750
19500
29250
39000
48750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.598
AC:
90861
AN:
151868
Hom.:
30128
Cov.:
31
AF XY:
0.605
AC XY:
44950
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.289
AC:
11936
AN:
41362
American (AMR)
AF:
0.688
AC:
10474
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.681
AC:
2361
AN:
3468
East Asian (EAS)
AF:
0.913
AC:
4729
AN:
5178
South Asian (SAS)
AF:
0.831
AC:
4003
AN:
4818
European-Finnish (FIN)
AF:
0.700
AC:
7393
AN:
10562
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.701
AC:
47646
AN:
67926
Other (OTH)
AF:
0.627
AC:
1325
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1541
3082
4622
6163
7704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.660
Hom.:
68959
Bravo
AF:
0.581
Asia WGS
AF:
0.814
AC:
2831
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.0
DANN
Benign
0.58
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs945748; hg19: chr1-103483514; COSMIC: COSV62177179; API